All In Biotech

Drug Trial Radar · NCT00856596

Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females

Efficacy Of Sertaconazole 2% (ERTACZO) in the Treatment of Interdigital Tinea Pedis With Once a Day Treatment for 4 Weeks

Last checked: Nov 20, 2026Latest source record: Aug 6, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

30

Planned (sponsor's estimate)

Start

Mar 2009

Primary completion

Aug 2009

Study completion Sep 2009

Sponsor

Lead sponsor
Jamaica Hospital Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Johnson & Johnson
First posted
Mar 6, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The topical cream, Sertaconazole (Ertaczo), has been FDA approved for the treatment of athlete's foot using twice a day dosing for 4 weeks. This study wants to see if sertaconazole will work equally as well with once a day dosing for 4 weeks for athlete's foot.

Conditions

  • Tinea Pedis
  • Athlete's Foot
  • Foot Fungus
  • Ringworm

Interventions

  • Sertaconazole nitrate cream 2%Drug

    Once a day topical cream

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To compare the efficacy and safety of sertaconazole 2% cream applied once a day for four weeks in the treatment of patients with KOH positive and culture positive symptomatic interdigital tinea pedis (athlete's foot).Time frame: Baseline visit, 1 week, 2 weeks, 4 weeks, 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jamaica Hospital Medical Center

    Jamaica, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.